Clinical Trial Update: Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple Instillation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing corneal residence time of chitosan-N-acetylcysteine eye drops in dry eye syndrome after single and multiple instillations; comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• Chitosan-N-acetylcysteine Eye Drops (Chitosan-N-acetylcysteine)

Snippet

Sponsor: Gerhard Garhofer | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED